Biodesix acquires Oncimmune’s laboratory and IPN malignancy test in US

Biodesix, a lung cancer diagnostic solutions company, has acquired UK-based Oncimmune’s laboratory and incidental pulmonary nodule (IPN) malignancy test in the US, to expand its ... Read More